5,6-dihydro-4H-4-(R)-ethylamino-6-(R)-methylthieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide hydrochloride

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: 5,6-dihydro-4H-4-(R)-ethylamino-6-(R)-methylthieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide hydrochloride
• 英文别名: (4R,6R)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydron;chloride
• 化学式: C₁₀H₁₆N₂O₄S₃*ClH
• 分子量: 360.907
• InChiKey: OSRUSFPMRGDLAG-CIRBGYJCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.03
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  151
• 氢给体数：
  3
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  (+/-)-(4S,6S;4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide 在 盐酸 作用下， 以 乙醇 为溶剂， 生成 5,6-dihydro-4H-4-(R)-ethylamino-6-(R)-methylthieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide hydrochloride
  参考文献：
  名称：

  Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCI

  摘要：

  本发明涉及一种改进的制备5,6-二氢-4-(S)-(乙基氨基)-6-(S)甲基-4H-噻吩[2,3b]噻吩吡啶-2-磺酰胺-7,7-二氧化氢盐酸盐的方法，其化学式为(I)，通常称为多索胺盐酸盐，可用作通过抑制碳酸酐酶酶来降低眼内压的药剂。

  公开号：

  US20060142595A1

文献信息

• [EN] PROCESS FOR PREPARING DORZOLAMIDE HYDROCHLORIDE AND ITS INTERMEDIATE<br/>[FR] PROCÉDÉ POUR LA PRÉPARATION DE CHLORHYDRATE DE DORZOLAMIDE ET SES INTERMÉDIAIRES
  申请人：SUVEN LIFE SCIENCES LTD

  公开号：WO2010061398A1

  公开（公告）日：2010-06-03

  The present invention relates to an improved process for the preparation of (4S,6S)-4- (ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide hydrochloride ("Dorzolamide hydrochloride") having formula 1. Dorzolamide hydrochloride is prepared by the process of the present invention with high chemical and diastereomeric purity. The present invention also relates to novel intermediate of the formula 20 and a process for its preparation. Dorzolamide hydrochloride is useful in the treatment of ocular hypertension by inhibiting carbonic anhydrase enzyme.

  本发明涉及一种改进的制备过程，用于制备(4S,6S)-4-(乙基氨基)-5,6-二氢-6-甲基-4H-噻吩[2,3-b]噻吩基喹噁啉-2-磺酰胺-7,7-二氧化氢盐酸盐（“多索胺盐酸盐”），其化学和对映体纯度高。本发明还涉及公式20的新型中间体及其制备过程。多索胺盐酸盐通过本发明的方法制备，可用于治疗青光眼，通过抑制碳酸酐酶酶起作用。
• WO2006/70387
  申请人：——

  公开号：——

  公开（公告）日：——
• REGULATION OF GENE EXPRESSION BY MODULATING PRIMARY CILIA LENGTH
  申请人：THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

  公开号：US20190015423A1

  公开（公告）日：2019-01-17

  The presently disclosed subject matter relates to methods of regulating gene expression in a cell by modulating the length of primary cilia of a cell, wherein such modulation can modulate the mechanosensitivity of the cell. The presently disclosed subject matter also provides for methods of treating ciliopathies and osteoporosis in a subject by increasing the length of primary cilia of a cell in a subject.
• Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCI
  申请人：Gurjar Keshao Mukund

  公开号：US20060142595A1

  公开（公告）日：2006-06-29

  The present invention relates to an improved process for the preparation of 5,6-dihydro-4-(S)-(ethylamino)-6-(S)methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide hydrochloride of formula (I) commonly known as Dorzolamide Hydrochloride useful as an agent to reduce intraoccular pressure by inhibiting carbonic anhydrase enzyme

  本发明涉及一种改进的制备5,6-二氢-4-(S)-(乙基氨基)-6-(S)甲基-4H-噻吩[2,3b]噻吩吡啶-2-磺酰胺-7,7-二氧化氢盐酸盐的方法，其化学式为(I)，通常称为多索胺盐酸盐，可用作通过抑制碳酸酐酶酶来降低眼内压的药剂。